Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the American Pharmacists Association : Japha|March 29, 2021
Clinical impact of a pharmacist + health coach chronic disease management program in a rural free clinicHaley Hurst, Starla Dunn, Kevin T Fuji, et al.
Blood Advances|April 9, 2024
Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndromeV Koneti Rao, Elaine Kulm, Jennifer Grossman, et al.
Annals of the American Thoracic Society|June 9, 2016
Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient CohortChuen-Yen Lau, Andrew D Mihalek, Jing Wang, et al.
Clinical Immunology (Orlando, Fla.)|November 19, 2024
A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysisV Koneti Rao, Anna Šedivá, Virgil A S H Dalm, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2023
Interim analysis: Open-label extension study of leniolisib for patients with APDSV Koneti Rao, Elaine Kulm, Anna Šedivá, et al.
Blood|November 18, 2022
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndromeV Koneti Rao, Sharon Webster, Anna Šedivá, et al.
Blood|October 4, 2017
Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisibV Koneti Rao, Sharon Webster, Virgil A S H Dalm, et al.
Pageof 1